End-Stage Renal Disease Increases Rates of Adverse Glucose Events When Treating Diabetic Ketoacidosis or Hyperosmolar Hyperglycemic State.

Schaapveld-Davis, Caitlin M; Negrete, Ana L; Hudson, Joanna Q; Saikumar, Jagannath; Finch, Christopher K; Kocak, Mehmet; Hu, Pan; Van Berkel, Megan A

Schaapveld-Davis, Caitlin M; Negrete, Ana L; Hudson, Joanna Q; Saikumar, Jagannath; Finch, Christopher K; Kocak, Mehmet; Hu, Pan; Van Berkel, Megan A.

Afiliação

Schaapveld-Davis CM; Methodist University Hospital, Memphis, TN.
Negrete AL; Methodist University Hospital, Memphis, TN.
Hudson JQ; University of Tennessee Health and Science Center College of Pharmacy, Memphis, TN.
Saikumar J; Methodist University Hospital, Memphis, TN.
Finch CK; University of Tennessee Health and Science Center College of Medicine, Memphis, TN.
Kocak M; Methodist University Hospital, Memphis, TN.
Hu P; University of Tennessee Health and Science Center College of Pharmacy, Memphis, TN.
Van Berkel MA; University of Tennessee Department of Preventative Medicine, Memphis, TN.

Clin Diabetes ; 35(4): 202-208, 2017 Oct.

Article em En | MEDLINE | ID: mdl-29109609

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Guideline / Observational_studies Idioma: En Revista: Clin Diabetes Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Tunísia

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google